Ginkgo Bio Rg-A
DNA
USD
STOCK MARKET:
NYX
Closed
 
...
Large gap with delayed quotes
Last quote
10/24/2025 - 22:15:00
Bid
10/24/2025 - 21:59:59
Bid
Volume
Ask
10/24/2025 - 21:59:59
Ask
Volume
13.57
+0.36 ( +2.73% )
13.57
2,800
13.58
3,200
More information
Analysis by TheScreener
24.10.2025
Evaluation Slightly negative  
Interest Strong  
Sensibility High  
Analysis date: 24.10.2025
Global Evaluation
  Slightly negative
The stock is classified in the slightly negative zone since 23.09.2025.
Interest
  Strong
Three stars since 14.10.2025.
Earnings Rev Trend
  Positive
 
Compared to seven weeks ago, the analysts have raised their earnings per share estimates. This positive trend began 14.10.2025 at a price of 14.09.
Evaluation
  Strongly overvalued
 
Based on its growth potential and our own criteria, we believe the share price is currently overvalued.
MT Tech Trend
  Positive
 
The dividend-adjusted forty day technical trend is positive since 23.09.2025.
4wk Rel Perf
  7.85%
 
The four-week dividend-adjusted overperformance versus SP500 is 7.85%.
Sensibility
  High
High, no change over 1 year.
Bear Market Factor
  High
On average, the stock has a tendency to amplify the drops in the index by 3.02%.
Bad News Factor
  Low
When the stock's pressure is specific, the market sanction on average is 7.10%.
Mkt Cap in $bn
  0.78
With a market capitalization <$2bn, GINKGO BIOWORKS HOLDINGS A is considered a small-cap stock.
G/PE Ratio
  2.56
A ratio (Forecasted Growth + Estimated Dividend Yield/ Estimated Price Earnings) higher than 1.6 often suggests the projected growth is a result of a base effect, meaning the company can often be in a turn around situation. In this case, the estimated PE is a better indicator of a stock's expected growth than the Long Term Growth (LT Growth).
LT P/E
  -2.90
The estimated PE is negative: the financial analysts' earnings estimates forecast a loss.
LT Growth
  7.43%
The annualized growth estimate is for the current year to 2026.
Avg. Nb analysts
  3
Over the last seven weeks, an average of 3 analysts provided earnings per share estimates.
Dividend Yield
  0.00%
The company is not paying a dividend.
Beta
  252
For 1% of index variation, the stock varies on average by 2.52%.
Correlation
  0.42
41.62% of stock movements are explained by index variations.
Value at Risk
  12.10
The value at risk is estimated at USD 12.10. The risk is therefore 89.20%. This value is based on the historical volatility for a medium time period (1 month) with a confidence of 95%.
First Analysis Date
  21.12.2021